Daniel Wellner

4.0k total citations · 1 hit paper
59 papers, 2.7k citations indexed

About

Daniel Wellner is a scholar working on Molecular Biology, Biochemistry and Clinical Biochemistry. According to data from OpenAlex, Daniel Wellner has authored 59 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 18 papers in Biochemistry and 9 papers in Clinical Biochemistry. Recurrent topics in Daniel Wellner's work include Amino Acid Enzymes and Metabolism (16 papers), Polyamine Metabolism and Applications (11 papers) and Metabolism and Genetic Disorders (9 papers). Daniel Wellner is often cited by papers focused on Amino Acid Enzymes and Metabolism (16 papers), Polyamine Metabolism and Applications (11 papers) and Metabolism and Genetic Disorders (9 papers). Daniel Wellner collaborates with scholars based in United States, Australia and Israel. Daniel Wellner's co-authors include Alton Meister, Eric J. Huang, Tang‐Yuan Chu, Philip Leder, Hans‐Werner Lahm, Karl Nocka, Peter Besmer, Jochen Buck, Edmund W. Hafner and C. Panneerselvam and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Daniel Wellner

58 papers receiving 2.5k citations

Hit Papers

The hematopoietic growth factor KL is encoded by the SI l... 1990 2026 2002 2014 1990 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Wellner United States 25 1.3k 562 368 307 270 59 2.7k
Indu Parikh United States 27 2.4k 1.9× 559 1.0× 117 0.3× 249 0.8× 590 2.2× 57 4.1k
Sumio Tanase Japan 35 1.7k 1.3× 515 0.9× 468 1.3× 129 0.4× 145 0.5× 91 3.2k
Takefumi Doi Japan 35 3.0k 2.3× 712 1.3× 187 0.5× 287 0.9× 243 0.9× 153 4.6k
Shoji Odani Japan 38 2.5k 1.9× 232 0.4× 116 0.3× 223 0.7× 315 1.2× 110 3.7k
Richard J. Reece United Kingdom 45 2.9k 2.2× 662 1.2× 175 0.5× 562 1.8× 318 1.2× 81 5.5k
G C Dubois United States 24 2.1k 1.6× 826 1.5× 153 0.4× 216 0.7× 413 1.5× 47 3.7k
S. Cervera March United States 8 1.2k 0.9× 376 0.7× 75 0.2× 218 0.7× 149 0.6× 11 2.5k
Justine S. Garvey United States 31 1.1k 0.8× 700 1.2× 74 0.2× 486 1.6× 189 0.7× 108 4.0k
André Trouet Belgium 30 2.2k 1.7× 321 0.6× 169 0.5× 349 1.1× 191 0.7× 96 4.4k
John C. Voyta United States 18 1.4k 1.0× 241 0.4× 118 0.3× 100 0.3× 140 0.5× 37 2.3k

Countries citing papers authored by Daniel Wellner

Since Specialization
Citations

This map shows the geographic impact of Daniel Wellner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Wellner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Wellner more than expected).

Fields of papers citing papers by Daniel Wellner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Wellner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Wellner. The network helps show where Daniel Wellner may publish in the future.

Co-authorship network of co-authors of Daniel Wellner

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Wellner. A scholar is included among the top collaborators of Daniel Wellner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Wellner. Daniel Wellner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sanyal, Amit, et al.. (2021). Evaluation of drug cost avoidance resulting from conduct of cancer clinical trials in a community-based oncology practice.. Journal of Clinical Oncology. 39(28_suppl). 66–66. 3 indexed citations
2.
Wellner, Daniel, et al.. (2012). Investigation and reduction of sub‐microgram peptide loss using molecular weight cut‐off fractionation prior to mass spectrometric analysis. Journal of Mass Spectrometry. 47(10). 1327–1332. 9 indexed citations
3.
Lee, Warren L., Benjamin D. Gold, Crystal M. Darby, et al.. (2008). Mycobacterium tuberculosis expresses methionine sulphoxide reductases A and B that protect from killing by nitrite and hypochlorite. Molecular Microbiology. 71(3). 583–593. 63 indexed citations
4.
Xu, Yan, Daniel Wellner, & David A. Scheinberg. (1997). Cryptic and regulatory epitopes in CD13/aminopeptidase N.. PubMed. 25(6). 521–9. 16 indexed citations
5.
Elion, Gertrude B., Charles N. Pegram, Craig J. Reist, et al.. (1996). L -Amino acid oxidase (LOX) modulation of melphalan activity against intracranial glioma. Cancer Chemotherapy and Pharmacology. 39(3). 179–186. 7 indexed citations
6.
Rich, Jeremy N., Gertrude B. Elion, Daniel Wellner, et al.. (1995). The effect ofl-amino acid oxidase on activity of melphalan against an intracranial xenograft. Cancer Chemotherapy and Pharmacology. 36(5). 379–384. 3 indexed citations
7.
Xu, Yuanyuan, Daniel Wellner, & David A. Scheinberg. (1995). Substance P and Bradykinin Are Natural Inhibitors of CD13/Aminopeptidase N. Biochemical and Biophysical Research Communications. 208(2). 664–674. 42 indexed citations
8.
Huang, Hsien‐Bin, Daniel Wellner, Ryno J. Naudé, et al.. (1994). Amino acid sequence and properties of vasopressin‐associated elephant neurophysin. International journal of peptide & protein research. 44(3). 270–277. 1 indexed citations
10.
Tate, Suresh S., et al.. (1988). Renal γ-glutamyl transpeptidases: Structural and immunological studies. Archives of Biochemistry and Biophysics. 262(2). 397–408. 29 indexed citations
11.
Panneerselvam, C., et al.. (1988). Bovine parathymosin: Amino acid sequence and comparison with rat parathymosin. Biochemical and Biophysical Research Communications. 155(2). 539–545. 10 indexed citations
12.
Panneerselvam, C., Daniel Wellner, & B.L. Horecker. (1988). The amino acid sequence of bovine thymus prothymosin α. Archives of Biochemistry and Biophysics. 265(2). 454–457. 34 indexed citations
13.
Wellner, Daniel, Keith C. Cheng, & Ursula Müller‐Eberhard. (1988). N-terminal amino acid sequences of the hemopexins from chicken, rat and rabbit. Biochemical and Biophysical Research Communications. 155(2). 622–625. 8 indexed citations
14.
Goldfarb, Valentina, Robert B. Trimble, Maria De Falco, et al.. (1986). An avian serum .alpha.1-glycoprotein, hemopexin, differing significantly in both amino acid and carbohydrate composition from mammalian (.beta.-glycoprotein) counterparts. Biochemistry. 25(21). 6555–6562. 23 indexed citations
15.
Stoner, Elizabeth, Harold Starkman, Daniel Wellner, et al.. (1984). Biochemical Studies of a Patient with Hereditary Hepatorenal Tyrosinemia: Evidence of Glutathione Deficiency. Pediatric Research. 18(12). 1332–1336. 32 indexed citations
16.
Wellner, Daniel & A Meister. (1981). A Survey of Inborn Errors of Amino Acid Metabolism and Transport in Man. Annual Review of Biochemistry. 50(1). 911–968. 64 indexed citations
17.
Wellner, Daniel. (1979). Stereospecific Sorption of L Amino Acids by Colloidal Clay. Science. 206(4417). 484–484. 5 indexed citations
18.
Wellner, Daniel, et al.. (1978). Pharmacokinetics of essential amino acids in chronic dialysis patients. American Journal of Clinical Nutrition. 31(9). 1652–1659. 21 indexed citations
19.
Greenfield, Robert S. & Daniel Wellner. (1977). Effects of threonine deaminase on growth and viability of mammalian cells in tissue culture and its selective cytotoxicity toward leukemia cells.. PubMed. 37(8 Pt 1). 2523–9. 6 indexed citations
20.
Wellner, Daniel. (1971). Electrofocusing in gels. Analytical Chemistry. 43(10). 59A–65a. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026